207 related articles for article (PubMed ID: 30124992)
1. Evaluation of isavuconazole MIC strips for susceptibility testing of Aspergillus and Scedosporium species.
Trovato L; Scalia G; Palermo CI; Costanzo CM; Oliveri S
Med Mycol; 2019 Jun; 57(4):429-433. PubMed ID: 30124992
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates.
Astvad KMT; Hare RK; Arendrup MC
Clin Microbiol Infect; 2017 Nov; 23(11):882-887. PubMed ID: 28373148
[TBL] [Abstract][Full Text] [Related]
3. Direct in vitro comparison of the prodrug isavuconazonium sulfate with the isavuconazole active compound against Aspergillus spp. and 2 rare moulds.
Pfaller MA; Rhomberg PR; Castanheira M
Diagn Microbiol Infect Dis; 2018 Sep; 92(1):43-45. PubMed ID: 29735424
[TBL] [Abstract][Full Text] [Related]
4. EUCAST Susceptibility Testing of Isavuconazole: MIC Data for Contemporary Clinical Mold and Yeast Isolates.
Jørgensen KM; Astvad KMT; Hare RK; Arendrup MC
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910898
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs.
Shivaprakash MR; Geertsen E; Chakrabarti A; Mouton JW; Meis JF
Mycoses; 2011 Sep; 54(5):e583-9. PubMed ID: 21518026
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of MIC Strip Isavuconazole Test for Susceptibility Testing of Wild-Type and Non-Wild-Type Aspergillus fumigatus Isolates.
Arendrup MC; Verweij P; Nielsen HV
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799223
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds.
Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
J Clin Microbiol; 2013 Aug; 51(8):2608-16. PubMed ID: 23740727
[TBL] [Abstract][Full Text] [Related]
8. Isavuconazole: A new broad-spectrum azole. Part 1: In vitro activity.
Denis J; Ledoux MP; Nivoix Y; Herbrecht R
J Mycol Med; 2018 Mar; 28(1):8-14. PubMed ID: 29534853
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan.
Yamazaki T; Inagaki Y; Fujii T; Ohwada J; Tsukazaki M; Umeda I; Kobayashi K; Shimma N; Page MG; Arisawa M
Int J Antimicrob Agents; 2010 Oct; 36(4):324-31. PubMed ID: 20674282
[TBL] [Abstract][Full Text] [Related]
10. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
Guinea J; Peláez T; Recio S; Torres-Narbona M; Bouza E
Antimicrob Agents Chemother; 2008 Apr; 52(4):1396-400. PubMed ID: 18212101
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.
Idelevich EA; Groß U; Becker K; Bader O
Diagn Microbiol Infect Dis; 2018 May; 91(1):52-54. PubMed ID: 29422272
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Rudramurthy SM; Chakrabarti A; Geertsen E; Mouton JW; Meis JF
Diagn Microbiol Infect Dis; 2011 Dec; 71(4):370-7. PubMed ID: 21937186
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017-2018.
Messer SA; Carvalhaes CG; Castanheira M; Pfaller MA
Diagn Microbiol Infect Dis; 2020 May; 97(1):115007. PubMed ID: 32081523
[TBL] [Abstract][Full Text] [Related]
14. EUCAST testing of Isavuconazole susceptibility in Aspergillus: comparison of results for Inoculum standardization using Conidium counting versus optical density.
Arendrup MC; Howard S; Lass-Flörl C; Mouton JW; Meletiadis J; Cuenca-Estrella M
Antimicrob Agents Chemother; 2014 Nov; 58(11):6432-6. PubMed ID: 25136005
[TBL] [Abstract][Full Text] [Related]
15. Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
Buil JB; Brüggemann RJM; Wasmann RE; Zoll J; Meis JF; Melchers WJG; Mouton JW; Verweij PE
J Antimicrob Chemother; 2018 Jan; 73(1):134-142. PubMed ID: 29048485
[TBL] [Abstract][Full Text] [Related]
16. Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method.
Espinel-Ingroff A; Chowdhary A; Gonzalez GM; Lass-Flörl C; Martin-Mazuelos E; Meis J; Peláez T; Pfaller MA; Turnidge J
Antimicrob Agents Chemother; 2013 Aug; 57(8):3823-8. PubMed ID: 23716059
[TBL] [Abstract][Full Text] [Related]
17. Revision of EUCAST breakpoints: consequences for susceptibility of contemporary Danish mould isolates to isavuconazole and comparators.
Jørgensen KM; Guinea J; Meletiadis J; Hare RK; Arendrup MC
J Antimicrob Chemother; 2020 Sep; 75(9):2573-2581. PubMed ID: 32556315
[TBL] [Abstract][Full Text] [Related]
18.
Pfaller MA; Rhomberg PR; Wiederhold NP; Gibas C; Sanders C; Fan H; Mele J; Kovanda LL; Castanheira M
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061288
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
Dellière S; Verdurme L; Bigot J; Dannaoui E; Senghor Y; Botterel F; Fekkar A; Bougnoux ME; Hennequin C; Guitard J
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844011
[TBL] [Abstract][Full Text] [Related]
20. Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method.
Howard SJ; Lass-Flörl C; Cuenca-Estrella M; Gomez-Lopez A; Arendrup MC
Antimicrob Agents Chemother; 2013 Nov; 57(11):5426-31. PubMed ID: 23959309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
